| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 514 | 2014 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 472 | 2017 |
| Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ... Gastroenterology 149 (7), 1804-1812. e4, 2015 | 443 | 2015 |
| Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical … L Aabakken, TH Karlsen, J Albert, M Arvanitakis, O Chazouilleres, ... Endoscopy 49 (06), 588-608, 2017 | 271 | 2017 |
| norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis P Fickert, GM Hirschfield, G Denk, HU Marschall, I Altorjay, M Färkkilä, ... Journal of hepatology 67 (3), 549-558, 2017 | 262 | 2017 |
| Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study PJ Trivedi, WJ Lammers, HR Van Buuren, A Parés, A Floreani, ... Gut 65 (2), 321-329, 2016 | 197 | 2016 |
| The gut-adherent microbiota of PSC–IBD is distinct to that of IBD MN Quraishi, M Sergeant, G Kay, T Iqbal, J Chan, C Constantinidou, ... Gut 66 (2), 386-388, 2017 | 174 | 2017 |
| overlap syndromes and autoimmune liver disease PJ Trivedi, GM Hirschfield Alimentary pharmacology & therapeutics 36 (6), 517-533, 2012 | 150 | 2012 |
| Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response PJ Trivedi, T Bruns, A Cheung, KK Li, C Kittler, T Kumagi, H Shah, ... Journal of hepatology 60 (6), 1249-1258, 2014 | 143 | 2014 |
| Recent advances in clinical practice: epidemiology of autoimmune liver diseases PJ Trivedi, GM Hirschfield Gut 70 (10), 1989-2003, 2021 | 136 | 2021 |
| Mucosal immunity in liver autoimmunity: a comprehensive review PJ Trivedi, DH Adams Journal of autoimmunity 46, 97-111, 2013 | 136 | 2013 |
| Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise PJ Trivedi, DH Adams Journal of Crohn's and Colitis 12 (suppl_2), S641-S652, 2018 | 129 | 2018 |
| Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age PJ Trivedi, H Crothers, J Mytton, S Bosch, T Iqbal, J Ferguson, ... Gastroenterology 159 (3), 915-928, 2020 | 121 | 2020 |
| Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis E Liaskou, LE Jeffery, PJ Trivedi, GM Reynolds, S Suresh, T Bruns, ... Gastroenterology 147 (1), 221-232. e7, 2014 | 115 | 2014 |
| Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival AJ Montano-Loza, BE Hansen, C Corpechot, D Roccarina, D Thorburn, ... Gastroenterology 156 (1), 96-107. e1, 2019 | 110 | 2019 |
| Indications, stains and techniques in chromoendoscopy PJ Trivedi, B Braden QJM: An International Journal of Medicine 106 (2), 117-131, 2013 | 108 | 2013 |
| Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo JA Fallowfield, AL Hayden, VK Snowdon, RL Aucott, BM Stutchfield, ... Hepatology 59 (4), 1492-1504, 2014 | 106 | 2014 |
| Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase CFM Perez, MH Harms, KD Lindor, HR Van Buuren, GM Hirschfield, ... Official journal of the American College of Gastroenterology| ACG 115 (7 …, 2020 | 101 | 2020 |
| Gut–liver immunity PJ Trivedi, DH Adams Journal of hepatology 64 (5), 1187-1189, 2016 | 93 | 2016 |
| Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity PJ Trivedi, T Bruns, S Ward, M Mai, C Schmidt, GM Hirschfield, CJ Weston, ... Journal of autoimmunity 68, 98-104, 2016 | 90 | 2016 |
